Does PHENPROCOUMON Cause Hepatosplenomegaly? 33 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Hepatosplenomegaly have been filed in association with PHENPROCOUMON. This represents 2.4% of all adverse event reports for PHENPROCOUMON.
33
Reports of Hepatosplenomegaly with PHENPROCOUMON
2.4%
of all PHENPROCOUMON reports
0
Deaths
33
Hospitalizations
How Dangerous Is Hepatosplenomegaly From PHENPROCOUMON?
Of the 33 reports, 33 (100.0%) required hospitalization.
Is Hepatosplenomegaly Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PHENPROCOUMON. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does PHENPROCOUMON Cause?
Anaemia (242)
General physical health deterioration (172)
Haematochezia (162)
Dyspnoea (140)
Gastrointestinal haemorrhage (122)
Overdose (109)
Dizziness (108)
Haematoma (108)
Product prescribing error (104)
Fall (92)
What Other Drugs Cause Hepatosplenomegaly?
METHOTREXATE (149)
PREDNISONE (91)
CYCLOPHOSPHAMIDE (87)
RITUXIMAB (87)
VINCRISTINE (81)
DEXAMETHASONE (80)
PREDNISOLONE (72)
TACROLIMUS (71)
ETOPOSIDE (69)
RUXOLITINIB (61)
Which PHENPROCOUMON Alternatives Have Lower Hepatosplenomegaly Risk?
PHENPROCOUMON vs PHENTERMINE
PHENPROCOUMON vs PHENTERMINE\TOPIRAMATE
PHENPROCOUMON vs PHENTOLAMINE
PHENPROCOUMON vs PHENYLEPHRINE
PHENPROCOUMON vs PHENYLEPHRINE\PHENYLEPHRINE